PRINCETON, N.J., May 17, 2021 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today its recent accomplishments and financial results for the quarter ended March 31, 2021. "This year continues to… Read More..
TORONTO, ON / ACCESSWIRE / May 14, 2021 / ADGS Advisory, Inc (OTC:QOEG), (the "Company"), a provider of leading-edge online education in the Asia Pacific region, today announced the formal completion of its name and ticker symbol change. Effective today, Friday May 14, 2021, the Company's stock will trade on… Read More..
CHICAGO & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Exicure, Inc.® (NASDAQ: XCUR), a pioneer in gene regulatory and immunotherapeutic drugs utilizing spherical nucleic acid (SNA™) technology, today announced the appointment of Brian C. Bock as the Company’s Chief Financial Officer (CFO) effective immediately. “Exicure’s proprietary SNA platform technology holds great potential for treating unmet… Read More..